-
Ebronucimab Injection Approved for Marketing by China NMPA
2025-02-19
Recently, the Ebronucimab Injection (trade name: 伊喜宁) of Kangrong Dongfang (Guangdong) Pharmaceutical Co., Ltd. is approved for marketing by China NMPA.
-
Renatus® Transcatheter Aortic Valve System Approved for Marketing
2025-02-19
Recently, the innovative product "Renatus® Transcatheter Aortic Valve System" of Beijing Balance Medical Technology Co., Ltd. is approved by China NMPA.
-
JETSTREAM™ PVCN100 Console and JETSTREAM™ Over-The-Wire Atherectomy Catheter Approved for Marketing
2025-02-19
Recently, the two innovative products "JETSTREAM™ PVCN100 Console" and "JETSTREAM™ Over-The-Wire Atherectomy Catheter" of Boston Scientific Corporation are approved by China NMPA.
-
Lumipulse® G HBsAg-Quant Approved for Marketing
2025-02-19
Recently, the innovative product "Lumipulse® G HBsAg-Quant" of Fujirebio Inc. is approved by China NMPA.
-
Navigational Positioning Microwave Ablation System Approved for Marketing
2025-02-19
Recently, the innovative product "Navigational Positioning Microwave Ablation System" of True Health (Beijing) Medical Technology Co., Ltd. is approved by China NMPA.
-
PulseSelect™ Pulsed Field Ablation (PFA) Generator and PulseSelect™ Pulsed Field Ablation (PFA) Loop Catheter Approved for Marketing
2025-02-19
Recently, the two innovative products "PulseSelect™ Pulsed Field Ablation (PFA) Generator" and "PulseSelect™ Pulsed Field Ablation (PFA) Loop Catheter" of Medtronic, Inc. are approved by China NMPA.